Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Contraceptive Devices market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Contraceptive Devices market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Contraceptive Devices market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Contraceptive Devices products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Contraceptive Devices products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Contraceptive Devices market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Contraceptive Devices development has been the leading industry trend of Contraceptive Devices market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Contraceptive Devices Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Male Contraceptive Devices, Female Contraceptive Devices, Other |
| By Application Outlook |
Hospital Pharmacy, Retail Pharmacy, E-Commerce, Online Pharmacy, Others |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Ansell, Church & Dwight, Actavis, Bayer, Merck & Co, Okamoto Industries, The Female Health Company, TodaySponge, HLL Lifecare, Agile Therapeutics, Caya, Teva Pharmaceutical, Condomi Health, Karex Industries, Medicines360 |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Ansell
- Church & Dwight
- Actavis
- Bayer
- Merck & Co
- Okamoto Industries
- The Female Health Company
- TodaySponge
- HLL Lifecare
- Agile Therapeutics
- Caya
- Teva Pharmaceutical
- Condomi Health
- Karex Industries
- Medicines360
Contraceptive Devices Market, By Type
- Male Contraceptive Devices
- Female Contraceptive Devices
- Other
Contraceptive Devices Market, By Application
- Hospital Pharmacy
- Retail Pharmacy
- E-Commerce
- Online Pharmacy
- Others
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Contraceptive Devices Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Contraceptive Devices Market Size Growth Rate by Product
1.4.2 Male Contraceptive Devices
1.4.3 Female Contraceptive Devices
1.5 Market by End User
1.5.1 Global Contraceptive Devices Market Size Growth Rate by End User
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacy
1.5.4 E-Commerce
1.5.5 Online Pharmacy
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Contraceptive Devices Market Size
2.1.1 Global Contraceptive Devices Revenue 2017-2027
2.1.2 Global Contraceptive Devices Sales 2017-2027
2.2 Contraceptive Devices Growth Rate by Regions
2.2.1 Global Contraceptive Devices Sales by Regions
2.2.2 Global Contraceptive Devices Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Contraceptive Devices Sales by Manufacturers
3.1.1 Contraceptive Devices Sales by Manufacturers
3.1.2 Contraceptive Devices Sales Market Share by Manufacturers
3.1.3 Global Contraceptive Devices Market Concentration Ratio (CR5 and HHI)
3.2 Contraceptive Devices Revenue by Manufacturers
3.2.1 Contraceptive Devices Revenue by Manufacturers (2017-2020)
3.2.2 Contraceptive Devices Revenue Share by Manufacturers (2017-2020)
3.3 Contraceptive Devices Price by Manufacturers
3.4 Contraceptive Devices Manufacturing Base Distribution, Product Types
3.4.1 Contraceptive Devices Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Contraceptive Devices Product Type
3.4.3 Date of International Manufacturers Enter into Contraceptive Devices Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Contraceptive Devices Sales by Product
4.2 Global Contraceptive Devices Revenue by Product
4.3 Contraceptive Devices Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Contraceptive Devices Breakdown Data by End User
6 North America
6.1 North America Contraceptive Devices by Countries
6.1.1 North America Contraceptive Devices Sales by Countries
6.1.2 North America Contraceptive Devices Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Contraceptive Devices by Product
6.3 North America Contraceptive Devices by End User
7 Europe
7.1 Europe Contraceptive Devices by Countries
7.1.1 Europe Contraceptive Devices Sales by Countries
7.1.2 Europe Contraceptive Devices Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Contraceptive Devices by Product
7.3 Europe Contraceptive Devices by End User
8 Asia Pacific
8.1 Asia Pacific Contraceptive Devices by Countries
8.1.1 Asia Pacific Contraceptive Devices Sales by Countries
8.1.2 Asia Pacific Contraceptive Devices Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Contraceptive Devices by Product
8.3 Asia Pacific Contraceptive Devices by End User
9 Central & South America
9.1 Central & South America Contraceptive Devices by Countries
9.1.1 Central & South America Contraceptive Devices Sales by Countries
9.1.2 Central & South America Contraceptive Devices Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Contraceptive Devices by Product
9.3 Central & South America Contraceptive Devices by End User
10 Middle East and Africa
10.1 Middle East and Africa Contraceptive Devices by Countries
10.1.1 Middle East and Africa Contraceptive Devices Sales by Countries
10.1.2 Middle East and Africa Contraceptive Devices Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Contraceptive Devices by Product
10.3 Middle East and Africa Contraceptive Devices by End User
11 Company Profiles
11.1 Ansell
11.1.1 Ansell Company Details
11.1.2 Company Business Overview
11.1.3 Ansell Contraceptive Devices Sales, Revenue and Gross Margin (2017-2020)
11.1.4 Ansell Contraceptive Devices Products Offered
11.1.5 Ansell Recent Development
11.2 Church & Dwight
11.2.1 Church & Dwight Company Details
11.2.2 Company Business Overview
11.2.3 Church & Dwight Contraceptive Devices Sales, Revenue and Gross Margin (2017-2020)
11.2.4 Church & Dwight Contraceptive Devices Products Offered
11.2.5 Church & Dwight Recent Development
11.3 Actavis
11.3.1 Actavis Company Details
11.3.2 Company Business Overview
11.3.3 Actavis Contraceptive Devices Sales, Revenue and Gross Margin (2017-2020)
11.3.4 Actavis Contraceptive Devices Products Offered
11.3.5 Actavis Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Company Business Overview
11.4.3 Bayer Contraceptive Devices Sales, Revenue and Gross Margin (2017-2020)
11.4.4 Bayer Contraceptive Devices Products Offered
11.4.5 Bayer Recent Development
11.5 Merck & Co
11.5.1 Merck & Co Company Details
11.5.2 Company Business Overview
11.5.3 Merck & Co Contraceptive Devices Sales, Revenue and Gross Margin (2017-2020)
11.5.4 Merck & Co Contraceptive Devices Products Offered
11.5.5 Merck & Co Recent Development
11.6 Okamoto Industries
11.6.1 Okamoto Industries Company Details
11.6.2 Company Business Overview
11.6.3 Okamoto Industries Contraceptive Devices Sales, Revenue and Gross Margin (2017-2020)
11.6.4 Okamoto Industries Contraceptive Devices Products Offered
11.6.5 Okamoto Industries Recent Development
11.7 The Female Health Company
11.7.1 The Female Health Company Company Details
11.7.2 Company Business Overview
11.7.3 The Female Health Company Contraceptive Devices Sales, Revenue and Gross Margin (2017-2020)
11.7.4 The Female Health Company Contraceptive Devices Products Offered
11.7.5 The Female Health Company Recent Development
11.8 TodaySponge
11.8.1 TodaySponge Company Details
11.8.2 Company Business Overview
11.8.3 TodaySponge Contraceptive Devices Sales, Revenue and Gross Margin (2017-2020)
11.8.4 TodaySponge Contraceptive Devices Products Offered
11.8.5 TodaySponge Recent Development
11.9 HLL Lifecare
11.9.1 HLL Lifecare Company Details
11.9.2 Company Business Overview
11.9.3 HLL Lifecare Contraceptive Devices Sales, Revenue and Gross Margin (2017-2020)
11.9.4 HLL Lifecare Contraceptive Devices Products Offered
11.9.5 HLL Lifecare Recent Development
11.10 Agile Therapeutics
11.10.1 Agile Therapeutics Company Details
11.10.2 Company Business Overview
11.10.3 Agile Therapeutics Contraceptive Devices Sales, Revenue and Gross Margin (2017-2020)
11.10.4 Agile Therapeutics Contraceptive Devices Products Offered
11.10.5 Agile Therapeutics Recent Development
11.11 Caya
11.12 Teva Pharmaceutical
11.13 Condomi Health
11.14 Karex Industries
11.15 Medicines360
12 Future Forecast
12.1 Contraceptive Devices Market Forecast by Regions
12.1.1 Global Contraceptive Devices Sales Forecast by Regions 2021-2027
12.1.2 Global Contraceptive Devices Revenue Forecast by Regions 2021-2027
12.2 Contraceptive Devices Market Forecast by Product
12.2.1 Global Contraceptive Devices Sales Forecast by Product 2021-2027
12.2.2 Global Contraceptive Devices Revenue Forecast by Product 2021-2027
12.3 Contraceptive Devices Market Forecast by End User
12.4 North America Contraceptive Devices Forecast
12.5 Europe Contraceptive Devices Forecast
12.6 Asia Pacific Contraceptive Devices Forecast
12.7 Central & South America Contraceptive Devices Forecast
12.8 Middle East and Africa Contraceptive Devices Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Contraceptive Devices Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
